
Introduction to ECHO and Biomarker Testing Guidelines Overview
This session provided an overview of the ECHO model, along with providing a data level-set of the current burden of lung cancer in each state, and provide a brief introduction to lung cancer biomarker testing, including the current guidelines and approved FDA biomarker-driven treatments.
View Resources
Lung Cancer Biomarker Testing ECHO – Texas – 9-19-2022 – Recording
Lung Cancer Biomarker Testing ECHO – Texas –9-19-2022 – Slides
Lung Cancer Biomarker Testing ECHO – Arkansas –9-22-2022 – Recording
Lung Cancer Biomarker Testing ECHO – Arkansas –9-22-2022 –Slides
Lung Cancer Biomarker Testing ECHO – Florida –9-22-2022 – Recording
Lung Cancer Biomarker Testing ECHO – Florida –9-22-2022 – Slides
Lung Cancer Biomarker Testing ECHO – Tennessee – 9-23-2022 – Recording
Lung Cancer Biomarker Testing ECHO – Tennessee – 9-23-2022 –Slides
Lung Biomarker Testing ECHO – Lousiana – 10-4-2022 – Recording
Lung Biomarker Testing ECHO – Lousiana – 10-4-2022 – Slides
Lung Biomarker Testing ECHO – West Virginia – 10-5-2022 – Recording
Lung Biomarker Testing ECHO – West Virginia – 10-5-2022 – Slides
Lung Biomarker Testing ECHO – South Carolina – 10-7-2022 – Recording
Lung Biomarker Testing ECHO – South Carolina – 10-7-2022 – Slides
Lung Cancer Biomarker ECHO – Virginia – 11-4-2022 – Slides
Lung Cancer Biomarker ECHO – Virginia – 11-4-2022 – Recording
2022-2023 Expansion Post Session 0 Resource Page
Understanding the Barriers and Pathways to Lung Cancer Biomarker Testing Central Hub
This session will provide an overview of the biomarker continuum through the lens of the critical medical stakeholders, showcasing the coordinated sequence of events that is required and the common gaps at every stage of the multidisciplinary care continuum.
Didactic Presenter
Raymond Osarogiagbon, MBBS, FACP
View Resources
Lung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Case Presentation
Lung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Recording
Lung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Slides
Lung Cancer Biomarker Testing ECHO – Post Resources Session 1 – Central Hub – October 2022
Understanding the Barriers and Pathways to Lung Cancer Biomarker Testing Eastern Hub
This session will provide an overview of the biomarker continuum through the lens of the critical medical stakeholders, showcasing the coordinated sequence of events that is required and the common gaps at every stage of the multidisciplinary care continuum.
Didactic Presenter
Suresh Ramalingam, MD, FASCO
Adequate Tissue for Sampling Central Hub
This session will define the overall role of the multidisciplinary care team, including the coordination by pathologists and medical oncologists to ensure adequate lung cancer tissue is collected for testing. Additionally, it will provide guidance on how to procure adequate tissue samples that allow for accurate characterization of histology, biomarker testing, and the tissue and discuss the approaches of the different proceduralists.
Didactic Presenter
Eric Flenaugh, MD, FCCP
Adequate Tissue for Sampling Eastern Hub
This session will define the overall role of the multidisciplinary care team, including the coordination by pathologists and medical oncologists to ensure adequate lung cancer tissue is collected for testing. Additionally, it will provide guidance on how to procure adequate tissue samples that allow for accurate characterization of histology, biomarker testing, and the tissue and discuss the approaches of the different proceduralists.
Didactic Presenter
Gerard Silvestri, MD, MS, FCCP
Choice of Panel, Interpretation of Results, and Next Steps - Central Hub
This session will provide guidance and recommendations regarding the appropriate biomarker testing modalities (next-generation sequencing (NGS), Fluorescence in situ hybridization (FISH), and blood. Additionally, it will discuss how to interpret the current NGS reports and the appropriate next steps, e.g. recommendations for FDA approved treatments or cancer clinical trials (if no FDA approved treatment exists, etc.).
Didactic Presenter
Ignacio Wistuba, MD
Choice of Panel, Interpretation of Results, and Next Steps – Eastern Hub
This session will provide guidance and recommendations regarding the appropriate biomarker testing modalities (next-generation sequencing (NGS), Fluorescence in situ hybridization (FISH), and blood. Additionally, it will discuss how to interpret the current NGS reports and the appropriate next steps, e.g. recommendations for FDA approved treatments or cancer clinical trials (if no FDA approved treatment exists, etc.).
Didactic Presenter
Ignacio Wistuba, MD
Improving Turnaround Time – Central Hub
This session will offer strategies to reduce turnaround time and present approaches to help ameliorate the patient’s wait time for the results.
Didactic Presenter
Lynette Sholl, MD, FCAP
Improving Turnaround Time - Eastern Hub
This session will offer strategies to reduce turnaround time and present approaches to help ameliorate the patient’s wait time for the results.
Didactic Presenters
Lynette Sholl, MD, FCAP
Texas - Biomarker Testing, Precision Medicine and Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
Cori Chandler
Arkansas- Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
Anas Abdurrahim, MHA
Louisiana - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
Marc Matrana , MD
Kevan Simms
Tennessee - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
J. Rob Headrick, MD
West Virginia - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Florida - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
Michael Diaz, MD
Virginia - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Didactic Presenters
Cori Chandler
South Carolina - Navigating Insurance Complexities
This session will explore the current coverage policies and reimbursement for single gene tests, as compared to multi-gene panel tests by private and public payers in each state and provide solutions to overcome reimbursement barriers.
Updates on Targeted Therapy
Didactic Presenters
Rami Manochakian, MD
Our Experts

Bruce Johnson, MD, FASCO
Chief Clinical Research Officer at Dana-Farber/Harvard Cancer Center
Past-President of the American Society of Clinical Oncology

Timothy Mullett, MD, MBA, FAC
Medical Director, Markey Cancer Center Network Development

Gerard Silvestri, MD, MS, FCCP
Hillenbrand Professor of Thoracic Oncology at Medical University of South Carolina
Immediate Past President of the American College of Chest Physicians

Suresh Ramalingam, MD, FASCO
Deputy Director, Winship Cancer Institute
Professor, Department of Hematology and Medical Oncology
Roberto C. Goizueta Distinguished Chair for Cancer Research
Director, Lung Cancer Program


Farhood Farjah, MD, MPH, FACS
Associate Professor of Surgery
Endowed Chair in Lung Cancer Research
Associate Medical Director for the Surgical Outcomes Research Center


Pierre De Delva, MD
Section Chief of General Thoracic Surgery
Associate Program Director, Cardiothoracic Fellowship Program

Zhonglin Hao, MD, PHD
Professor of Medicine and Cancer Biology and Medical Director

Eric Flenaugh, MD, FCCP
Director of Advanced Diagnostic Interventional Pulmonary Medicine
Lung Nodule Clinic Physician Director

Raymond Osarogiagbon, MBBS, FACP
Director, Multidisciplinary Thoracic Oncology Program

Michal Senitko, MD, DAABIP
Section Chief, Interventional Pulmonology and Assistant Professor of Medicine and Surgery at the University of Mississippi Medical Center
Co-Director Lung Cancer Screening Program at UMMC Cancer Center and Research Institute

Ignacio Wistuba, MD
Division Head and interim, Division of Pathology/Lab Medicine Professor
Chair, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine

Jhanelle E. Gray, MD
Program Co-Leader, Molecular Medicine
Chair, Department of Thoracic Oncology


Rami Manochakian, MD
Associate Professor of Medicine
Consultant, Thoracic Oncology
Program Director, Hematology/Oncology Fellowship

Luis Raez, MD
Chief Scientific Officer & Medical Director
Co-Director MCI/FAU Florida Cancer Center of Excellence
Memorial Cancer Institute


Estelamari Rodriguez, MD
Associate Director of Community Outreach- Thoracic Oncology
University of Miami Health System

Sajjad A. Bhatti, MD
University Of Arkansas for Medical Sciences

Sam Makhoul, MD

Humdum Durrani, MD

Sheena Bhalla, MD
Assistant Professor | Internal Medicine – Hematology/Oncology

Farrah Kheradmand, MD
Professor | Medicine-Pulmonary Baylor College of Medicine

Bryan Burt, MD, FACS
Professor and Chief, Division of Thoracic Surgery
Department of Surgery


Philip Edward Lammers, MD

J. Rob Headrick, MD

Melissa Johnson, MD


Brian G. Fuller, MD


Sarah Thayer, MD, PhD

Troy Richards, MD

David Chambers, MD

Ira Surolia, MD

Robert White, MD, FACS

Kavitha Beedupalli, MD

Robert Holladay, MD, FCCP

Carlos Previgliano, MD

Adam Fox, MD

Jessica Forcucci, MD

Mariam Alexander, MD

Claudia Miller, BSN, RN, ONC, ONN-CG

Sean Callahan, MD

Howard Li, MD

Renato Martins, MD

Richard “Rick” Hall, MD

Edward Stelow, MD

Rayan Ihle, MD

Yousef Shweihat, MD

Ghulam Abbas, MD

William Mangano, MD

Jean Bustamante-Alvarez, MD

Amy Deipolyi, MD

Lori Russell, RN OCN
Lung Cancer Biomarker Testing ECHO – Texas – 9-19-2022 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Florida –9-22-2022 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Arkansas –9-22-2022 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Arkansas –9-22-2022 –Slides
View MoreLung Cancer Biomarker Testing ECHO – Tennessee – 9-23-2022 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Tennessee – 9-23-2022 –Slides
View MoreLung Cancer Biomarker Testing ECHO – Florida –9-22-2022 – Recording
View MoreVideo
Lung Biomarker Testing ECHO – South Carolina – 10-7-2022 – Slides
View MoreLung Biomarker Testing ECHO – Lousiana – 10-4-2022 – Slides
View MoreLung Biomarker Testing ECHO – Lousiana – 10-4-2022 – Recording
View MoreVideo
Lung Biomarker Testing ECHO – South Carolina – 10-7-2022 – Recording
View MoreVideo
Lung Biomarker Testing ECHO – West Virginia – 10-5-2022 – Slides
View MoreLung Biomarker Testing ECHO – West Virginia – 10-5-2022 – Recording
View MoreVideo
2022-2023 Expansion Post Session 0 Resource Page
View MoreLung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Case Presentation
View MoreLung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Central Hub – 10-14-2022 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 1 – Central Hub – October 2022
View MoreLung Cancer Biomarker Testing ECHO – Eastern Hub – 10-24-22 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 1 – Eastern Hub – October 2022
View MoreLung Cancer Biomarker ECHO – Virginia – 11-4-2022 – Slides
View MoreLung Cancer Biomarker ECHO – Virginia – 11-4-2022 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Post Resources Session 2 – Central Hub – November 2022
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 2 – Eastern Hub – November 2022
View MoreLung Biomarker Testing ECHO – Central Hub- 11-11-22 – Recording
View MoreVideo
Lung Biomarker Testing ECHO – Central Hub- 11-11-22 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 3 – Central Hub – January 2023
View MoreLung Cancer Biomarker Testing ECHO – Central Hub – 01-27-23 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Central Hub – 01-27-23 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Post Resources Session 3 – Eastern Hub – January 2023
View MoreLung Cancer Biomarker Testing ECHO – Eastern Hub – 01-18-23 – Slides
View MoreLung Cancer Biomarker Testing – Session 5 – Florida – Resources
View MoreLung Cancer Biomarker Testing ECHO – Florida – 3-3-23 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 4 – Central Hub – February 2023
View MoreLung Cancer Biomarker Testing ECHO – Post Resources Session 4 – Eastern Hub – February 2023
View MoreLung Cancer Biomarker Testing ECHO – Central Hub – 2-17-23 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Florida – 3-3-23 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Central Hub – 2-17-23 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Florida –4-12-2023 – Recording
View MoreVideo
Lung Cancer Biomarker Testing ECHO – Florida –4-12-2023 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Tennessee –3-24-2023 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Virginia –3-21-2023 – Slides
View MoreLung Cancer Biomarker Testing ECHO – Tennessee –3-24-2023 – Recording
View MoreVideo
Financial Support Provided By
Get Involved
Complete the fields below to learn more about how the American Cancer Society uses the ECHO Model to fight cancer on all fronts, inquire about an upcoming ECHO, or to learn how you can join us in our mission to save lives, celebrate lives, and lead the fight for a world without cancer.
